Artigo de periodico

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections (2023)

• Authors:
  • Reinke, Patrick Y. A
  • Souza, Edmarcia Elisa de
  • Günther, Sebastian
  • Falke, Sven
  • Lieske, Julia
  • Ewert, Wiebke
  • Loboda, Jure
  • Herrmann, Alexander
  • Mashhour, Aida Rahmani
  • Karnicar, Katarina
  • Usenik, Aleksandra
  • Lindic, Natasa
  • Sekirnik, Andreja
  • Botosso, Viviane Fongaro
  • Machado-Santelli, Glaucia Maria
  • Kapronezai, Josana
  • Araujo, Marcelo Valdemir de
  • Pereira, Taiana Tainá Silva
  • Souza Filho, Antonio Francisco de
  • Tavares, Mariana Silva
  • Flórez-Álvarez, Lizdany
  • Oliveira, Danielle Bruna Leal de
  • Durigon, Edison Luiz
  • Giaretta, Paula Roberta
  • Heinemann, Marcos Bryan
  • Hauser, Maurice
  • Seychell, Brandon
  • Böhler, Hendrik
  • Rut, Wioletta
  • Drag, Marcin
  • Beck, Tobias
  • Cox, Russell
  • Chapman, Henry N.
  • Betzel, Christian
  • Brehm, Wolfgang
  • Hinrichs, Winfried
  • Ebert, Gregor
  • Latham, Sharissa L.
  • Guimarães, Ana Marcia de Sá
  • Turk, Dusan
  • Wrenger, Carsten
  • Meents, Alke
• USP affiliated authors: SANTELLI, GLAUCIA MARIA MACHADO - ICB ; DURIGON, EDISON LUIZ - ICB ; HEINEMANN, MARCOS BRYAN - FMVZ ; GUIMARÃES, ANA MARCIA DE SÁ - ICB ; WRENGER, CARSTEN - ICB ; SOUZA, EDMARCIA ELISA DE - ICB ; PEREIRA, TAIANA TAINÁ SILVA - ICB ; ÁLVAREZ, LIZDANY FLÓREZ - ICB ; SOUZA FILHO, ANTONIO FRANCISCO DE - ICB ; ÁLVAREZ, LIZDANY FLÓREZ - ICB
• Unidades: ICB; FMVZ
• DOI: 10.1038/s42003-023-05317-9
• Subjects: COVID-19; INIBIDORES DE ENZIMAS; ENZIMAS PROTEOLÍTICAS; ANTIVIRAIS; INFECÇÕES POR CORONAVIRUS
• Agências de fomento:
  • Financiamento FAPESP
  • Financiamento CAPES
• Language: Inglês
• Imprenta:
  • Publisher place: Berlin
  • Date published: 2023
• Source:
  • Título: Communications Biology
  • ISSN: 2399-3642
  • Volume/Número/Paginação/Ano: v. 6, art. 1058, p. 1-13, 2023

Informações sobre o DOI: 10.1038/s42003-023-05317-9 (Fonte: oaDOI API)
• Este periódico é de acesso aberto
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: gold
• Licença: cc-by

---

Download do texto completo

Tipo	Nome	Link
	HEI_145_3161232_R.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  REINKE, Patrick Y. A et al. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections. Communications Biology, v. 6, p. 1-13, 2023Tradução . . Disponível em: https://doi.org/10.1038/s42003-023-05317-9. Acesso em: 29 dez. 2025.

• APA

  Reinke, P. Y. A., Souza, E. E. de, Günther, S., Falke, S., Lieske, J., Ewert, W., et al. (2023). Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections. Communications Biology, 6, 1-13. doi:10.1038/s42003-023-05317-9

• NLM

  Reinke PYA, Souza EE de, Günther S, Falke S, Lieske J, Ewert W, Loboda J, Herrmann A, Mashhour AR, Karnicar K, Usenik A, Lindic N, Sekirnik A, Botosso VF, Machado-Santelli GM, Kapronezai J, Araujo MV de, Pereira TTS, Souza Filho AF de, Tavares MS, Flórez-Álvarez L, Oliveira DBL de, Durigon EL, Giaretta PR, Heinemann MB, Hauser M, Seychell B, Böhler H, Rut W, Drag M, Beck T, Cox R, Chapman HN, Betzel C, Brehm W, Hinrichs W, Ebert G, Latham SL, Guimarães AM de S, Turk D, Wrenger C, Meents A. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections [Internet]. Communications Biology. 2023 ; 6 1-13.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1038/s42003-023-05317-9

• Vancouver

  Reinke PYA, Souza EE de, Günther S, Falke S, Lieske J, Ewert W, Loboda J, Herrmann A, Mashhour AR, Karnicar K, Usenik A, Lindic N, Sekirnik A, Botosso VF, Machado-Santelli GM, Kapronezai J, Araujo MV de, Pereira TTS, Souza Filho AF de, Tavares MS, Flórez-Álvarez L, Oliveira DBL de, Durigon EL, Giaretta PR, Heinemann MB, Hauser M, Seychell B, Böhler H, Rut W, Drag M, Beck T, Cox R, Chapman HN, Betzel C, Brehm W, Hinrichs W, Ebert G, Latham SL, Guimarães AM de S, Turk D, Wrenger C, Meents A. Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections [Internet]. Communications Biology. 2023 ; 6 1-13.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1038/s42003-023-05317-9

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• West Nile virus - a re-emerging global threat: recent advances in vaccines and drug discovery
• Editorial: Emerging human viruses with pandemic potential: Diagnostics, pathogenesis, and therapeutics
• Sperm viability, serological, molecular, and modified seminal plasma agglutination tests in the diagnosis of Leptospira in the semen and serum of bovine bulls
• Identification of clonal complexes of Mycobacterium bovis in Brazil
• Diversification of gene content in the Mycobacterium tuberculosis complex is determined by phylogenetic and ecological signatures
• Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine
• Genome sequencing of Mycobacterium pinnipedii strains: genetic characterization and evidence of superinfection in a South American sea lion (Otaria flavescens)
• Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease
• Hemorrhagic fever viruses: pathogenesis, therapeutics, and emerging and re-emerging potential
• Plant-derived extracts and natural products with antiviral activity